Viewing Study NCT00985959

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:06 PM
Ignite Modification Date: 2026-03-09 @ 8:37 AM
Study NCT ID: NCT00985959
Status: COMPLETED
Last Update Posted: 2013-12-02
First Post: 2009-09-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT)
Sponsor: Janssen Pharmaceutical K.K.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple myeloma View
None Hematopoietic stem cell transplant View
None HSCT View
None Melphalan View
None Prednisolone View
None Bortezomib View
None JNJ-26866138 View